SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (553)3/31/2015 4:18:03 PM
From: Jibacoa  Respond to of 566
 
RIGL is among my best performing stocks today.<g>
It is in 3rd place % wise, after COPD and CRMD, which are having double digit gains. <g>
RIGL has almost completely closed the UG of Feb23, the day it announced the BMY deal.
But the H of that day at the 3.91 level is the first resistance it will have to go through before it could reach Jefferies target.<g>
Other resistance points or possible obstacles it will have to conquer before reaching the $10 "target" are:
The Jun2014 H at 4.20; the March 2014 double top at the $5 level; the April 2013 at the 7.21 level and then
there is a large resistance from the $8 to the $9.90 <g>
The last time it traded above 10 was in Oct2012 when the H was 10.34
In Feb,Jul and Sep 2012 it also traded above 10, and the H in Dec 2007 was 31, The all time H that I rember was in 2002, in the high 40s. <g>
Although I like Jefferies target of $10, for this Yr, I would just be satisfied with March 2014 H at the $5 level.<g>

Bernard